Okay, let's tackle this question about Graft versus Host reaction. The user provided the question but didn't fill in the options, which is a bit tricky. But since the correct answer is already given, maybe I can infer the options from the standard ones for this topic.

First, the core concept here is Graft versus Host Disease (GVHD). I need to explain that GVHD occurs when donor immune cells attack the recipient's tissues. The key here is that the donor's T cells recognize the recipient's cells as foreign.

The correct answer is probably related to the donor's immune system. Common options for this question might include things like "Donor T-cells", "Recipient T-cells", "Donor B-cells", or maybe something about the type of graft. Since GVHD is caused by donor T-cells attacking the host, the correct answer would be the option that mentions donor T-cells.

For the incorrect options, if there's an option about recipient T-cells, that's wrong because they don't attack in GVHD. Similarly, if there's an option about B-cells, they're not the main culprits here. Maybe another option could be about a specific type of graft, like allograft versus autograft. Allografts are from another person, so GVHD is possible there, but if an option says autograft, that's incorrect because it's the same person's tissue.

The clinical pearl should highlight that GVHD is a risk in allogeneic transplants, especially bone marrow or stem cell transplants. It's important to note that T-cell depletion can prevent GVHD but might increase the risk of relapse in the recipient's original disease.

Putting it all together, the explanation needs to be concise, fit into the character limit, and cover all sections as specified. Let me structure each part step by step, making sure not to exceed the word count and to use the correct formatting.

**Core Concept**
Graft versus Host Disease (GVHD) arises when donor immune cells recognize the recipient's tissues as foreign and mount an immune attack. It occurs exclusively in **allogeneic** transplants (donor ≠ recipient), particularly with **T-cell-rich grafts**. The pathophysiology involves donor T-cells recognizing recipient major histocompatibility complex (MHC) molecules as non-self.

**Why the Correct Answer is Right**
The correct answer is **Donor T-cells**. After allogeneic hematopoietic stem cell transplantation, donor T-cells in the graft become activated by recipient antigen-presenting cells (APCs) via direct recognition of MHC class I/II molecules. This triggers cytokine release (e.g., TNF-α, IFN-γ) and cytotoxic T-cell-mediated destruction of recipient tissues, especially the skin, liver, and gastrointestinal tract. Pre-transplant conditioning (e.g., chemotherapy) further reduces recipient immune surveillance, allowing donor T-cells to proliferate unchecked.

**Why Each Wrong Option is Incorrect**
**Option A:** Recipient T-cells are irrelevant in GVHD; they are suppressed or eliminated during conditioning.
**Option B:** Donor B-cells do not initiate GVHD; they may later produce antibodies but are not primary effectors.
**Option D:** Autologous transplants (recipient as donor) lack immunologic disparity,

✓ Correct Answer: B. T-Lymphocytes